InvestorInvestor relations

Application of Rehabilitation Patients’ Plasma in Corona Virus Disease 2019 (COVID-19)

Application of Rehabilitation Patients’ Plasma in Corona Virus Disease 2019 (COVID-19)

On February 15, 2020, with the support of Xinxiang government, Hualan Bio jointed with Xinxiang Central Blood Station to collect the plasma of two rehabilitation patients suffering from Corona Virus Disease 2019 (COVID-19) who voluntarily donated plasma. After the collection, inactivate the virus, and according to the regulation of document [2020] 128 "Clinical Treatment Protocol of Plasma of Rehabilitation Patients Suffering from Corona Virus Disease 2019 (COVID-19) during Recovery Period (trial version 1)" issued by National Health Commission of the People’s Republic of China to perform quality tests for blood virus, antibody for COVID-19 and etc. After all tests are qualified and the special immune plasma for clinical treatment is successfully prepared, the plasma will be used for clinical treatment of critically patients.

Since the outbreak of COVID-19, Hualan Bio have participated in the prevention and control of the epidemic through various ways. In addition to the production, supply and R&D of emergency drugs, on January 29, 2020, in conjunction with relevant units, Hualan Bio applied the project "Research on Application of Plasma Treatment during Recovery Period in Severe COVID-19" to the Henan Science and Technology Department, and the company have started relevant research work.

Hualan | Hualan Biological

 


TAG:  Hualan Bio, Corona Virus Disease 2019, COVID-19, Plasma Treatment